Molecular Diagnostics Market Size [2022-2028] | is Projected to Reach USD 13.87 Billion, with 7.1% CAGR

Wednesday, February 2, 2022 at 8:13am UTC

Pune, India, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The global molecular diagnostics market is projected to grow with rising technological developments in molecular diagnostic techniques. These advancements are intended to offer higher accuracy, cost-effectiveness, and portability which further drives the market. This information was published by Fortune Business Insights in a report, titled “Molecular Diagnostics Market Size, Share and Global Trend By Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025” offering insights on factors influencing growth.

The global market covered a value of USD 8.01 Billion in the year 2017 and is projected to reach USD 13.87 Billion by 2025. As per the report, the global market is expected to garner a healthy CAGR of 7.1% throughout the forecast period.   

Get Sample PDF Brochure:

Infectious Diseases: The Largest Growing Segment Among Other Applications

Among applications, infectious diseases segment is expected to account for a majority of share in the global molecular diagnostic market. The scope of this segment is increasing owing to the rising number of patients suffering from infections and microbial outbreaks. Moreover, the infectious diseases segment covered a share of 60% in the year 2017. Development of tests for several diseases and rising awareness about the benefits of adopting molecular diagnostic technologies may prevent the occurrence of infectious diseases. Global organizations such as World Bank and the World Health Organization (WHO) are planning to conduct awareness programs to increase the talent pool for molecular diagnostics.

North America Continues to Maintain Its Stronghold until 2025

“Well-established healthcare infrastructure, combined with the rising incidence of cancer is helping the market grow in North America,” stated a lead analyst at Fortune Business Insights. “Developed healthcare systems further helps in the easy availability and accessibility of advanced instruments such as molecular diagnostics. In 2017, this regional market was valued at US$ 3639.4 Mn and is likely to lead the global landscape through the forecast period. The rising collaborations and association between research hospitals and academic institutions encourages growth of the market in this region. Both the bodies are involving in continuous discussions for process improvements in molecular diagnosis.

To get to know more about the short-term and long-term impact of COVID-19 on this market,

Please Visit:

Transformation in Healthcare May Lead to Innovative Molecular Diagnostic Systems

The evolution of molecular diagnosis over the years has given birth to different molecular diagnostic tests. These tests help to detect specific RNA or DNA sequences. In addition to this, they help to get an understanding if these sequences are associated with diseases or not. With the rapid transformation of healthcare, innovative molecular diagnostic tests are likely to introduce in the coming years. This will further transform the molecular biology field. Other factors driving the molecular diagnostic market are rising demand for healthcare facilities and personalized medicine. Furthermore, several favourable policies by governments with an aim to encourage care diagnosis and increase awareness about diagnostic procedures drives the market.    

Speak To Our Analyst:

Lack of Experts to Conduct Molecular Diagnostic Tests May Hamper the Growth

Although the market is growing at a rapid pace, there are certain factors that may restrict the growth. The molecular diagnostic tests are expensive, which makes it difficult for people with low-income groups to afford these tests. Also, lack of experts to handle such instruments especially in developing countries may impede the growth to some extent. However, with the advent of advanced technology, introduction of new molecular diagnostic systems may help to overcome such challenges.

Abbott Launched a Next Generation System Used for Molecular Diagnosis

The global molecular diagnostics market is expected to be dominated by companies such as Danaher, Abbott, QIAGEN, and F. Hoffmann-La Roche Ltd. Strong supply chain network, rising research and development (R&D) activities, and development strategies are likely to create growth opportunities for the above companies. In 2016, Abbott announced the introduction of a next-generation system called Alinity.

This system is used for plasma and blood screening, haematology procedures, molecular diagnostics, and clinical chemistry. Companies are focussing on to develop new molecular diagnostic tests, which may foster growth of the market. In 2018, Banyan Biomakers received marketing authorization from the U.S. FDA on its first blood diagnostic test. This test was developed to treat traumatic brain injuries which is also referred to as concussion among adults. These developments are likely to have a positive impact on the overall market.

Quick Buy - Molecular Diagnostics Market Research Report:

Table Of Contents :

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Porter's five forces analysis
    • Top 3 players working in market space
    • Key developments (Merger, Acquisitions, etc.)
    • Technological Advancements
  • Global Molecular Diagnostics Market Analysis, Insights and Forecast, 2014-2025
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product Type
      • Instruments
      • Reagents & Consumables
    • Market Analysis, Insights and Forecast – By Application
      • Infectious Disease
      • Blood Screening
      • Histology
      • Oncology
      • Others
    • Market Analysis, Insights and Forecast – By Technique
      • Amplification Techniques
      • Hybridization Techniques
      • Sequencing Techniques
      • Others
    • Market Analysis, Insights and Forecast – By End User
      • Clinical & Pathology Labs
      • Hospitals
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Middle East & Africa
      • Latin America

Ask for Customization of this Report:

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245


Primary Logo